American Society of Retina Specialists
An ophthalmologist and retina specialist, Dr. Roger T. Adler has worked in the field of medicine for more than 20 years. In addition to serving as a doctor at Bond Eye Associates offices in Peoria, Pekin, and Canton, Illinois, Dr. Roger T. Adler is a member of many professional associations including the American Society of Retina Specialists.
The largest organization of its kind, the ASRS is a community of close to 3,000 retina specialists across the United States and around the world. The association is dedicated to expanding research and education opportunities for doctors and advocating for beneficial legislation. One of the society’s many advocacy campaigns included a fight to gain greater access for eye specialists to the drug Avastin, the trade name for the medication bevacizumab.
A 2012 outbreak of fungal meningitis complicated patient access to this drug, which has been found effective for conditions such as age-related macular degeneration. The campaign resulted in the collection of hundreds of letters from ASRS members recommending the Food and Drug Administration (FDA) extend the recently shortened beyond-use dates of “repackaged” bevacizumab; the ASRS argued this restriction by the FDA makes the drug unobtainable for many retina specialists and their patients.
In January, 2017, a revised version of the FDA document pertaining to this matter was released which indicated a step in favor of the ASRS argument – the allowable beyond-use date had been extended.
CHICAGO (May 2013) – The American Society of Retina Specialists (ASRS) is pleased to announce the dates for its 2013 Annual Meeting, which will be held Aug. 24-28, 2013, at the Sheraton Centre Toronto in Toronto, Ontario, Canada. The ASRS hosts this event for its more than 2,400 members from 55 countries, including longtime ASRS member Dr. Roger T. Adler. Dr. Roger Adler serves as a clinical ophthalmologist and retina specialist at Eye Specialists of Ohio.
Now in its 31st year, the ASRS annual meeting will feature scientific sessions, panel discussions, and surgical case conferences regarding the latest advances in retinal ophthalmology. Additionally, this year’s meeting will unveil the Retinal Innovation Forum, which provides information to members on the most cutting-edge developments in retinal science, business, and technology.
As the largest retinal association in the world, the ASRS is comprised of more than 2,400 members, representing all 50 states in the United States, Puerto Rico, and the District of Columbia, and more than 55 countries worldwide. The organization is dedicated to promoting the treatment and understanding of vitreoretinal diseases and to assisting its members in providing the highest quality of care to their patients.
In his current position at Bond Eye Associates, Dr. Roger T. Adler treats patients with conditions such as retinal detachment, ocular inflammation, and macular degeneration, among others. In addition to the American Society of Retina Specialists, Dr. Roger Adler maintains membership in the American College of Eye Surgeons, the American Academy of Ophthalmologists, and the American Medical Association.